Table 1 Baseline clinical characteristics.

From: Prognostic impact and predictors of persistent renal dysfunction in acute kidney injury after percutaneous coronary intervention for acute myocardial infarction

 

Persistent AKI

Transient AKI

No AKI

P value

Age, year

77 (70.5–85)*

73 (66.5–83.5)†

69 (60–76)*,†

< 0.001

Age > 75 years

14 (56.0)*

25 (43.9)†

216 (27.2)*,†

0.0003

Male gender

16 (64.0)

44 (77.2)

618 (77.3)

0.27

Diabetes mellitus

10 (40.0)

31 (54.4)†

270 (34.0)†

0.007

Dyslipidemia

11 (44.0)

28 (50.0)

447 (56.2)

0.33

Hypertension

17 (68.0)

42 (73.7)

519 (65.3)

0.42

History of MI

1 (4.0)

5 (8.8)

44 (5.5)

0.56

Stroke

4 (16.0)

6 (10.5)

55 (6.9)

0.15

PAD

2 (8.0)

4 (7.0)

17 (2.1)

0.02

Hb, g/dL

13.2 (12.2–14.8)

13.3 (11.1–15.2)†

14.2 (13.0–15.2)†

0.0019

Anemia

14 (56.0)*

29 (50.9)†

204 (25.7)*,†

< 0.0001

SCr, mg/dL

1.00 (0.67–1.33)

1.02 (0.74–1.37)†

0.86 (0.72–1.02)†

0.0019

eGFR, mL/min/1.73 m2

52.2 (40.2–74.0)

53.1 (37.8–77.5)†

66.6 (53.5–78.4)†

0.0004

HbA1c

6.5 (5.7–7.2)

6.3 (5.8–7.1)

6.0 (5.7–6.8)

0.15

Max CKMB, IU/L

312 (155–481)

190 (77–378)

186 (88–345)

0.06

EF, %

46.0 (36.0–58.0)*

52.7 (42.8–66.1)

58.0 (50.0–64.0)*

0.0002

EF < 40%

7 (30.4)*

12 (23.1)†

52 (6.7)*,†

< 0.0001

Medication

 ARB, ACE-Is or ARNI

11 (44.0)

26 (45.6)†

230 (29.2)†

0.016

 β-blocker

7 (28.0)

7 (12.5)

62 (8.0)

0.051

 Statin

8 (32.0)

20 (35.1)

169 (21.5)

0.36

  1. Unless otherwise indicated, the values are presented as medians (interquartile ranges) or n (%).
  2. MI myocardial infarction, PAD peripheral artery disease, Hb hemoglobin, SCr serum creatinine, eGFR estimated glomerular filtration rate, CKMB creatine kinase MB, EF ejection fraction, ARB angiotensin II receptor blocker, ACE-Is angiotensin-converting enzyme inhibitors, ARNI angiotensin receptor neprilysin inhibitor.
  3. *Persistent AKI vs. No AKI, P < 0.017 (Bonferroni correction). †Transient AKI vs No AKI, P < 0.017 (Bonferroni correction).
  4. Significant values are in bold.
Back to article page